- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Immunovia publ AB (IMMNOV)
Immunovia publ AB stock price live, this page displays ST IMMNOV stock exchange data. View the IMMNOV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Immunovia publ AB real time stock price chart below.
What Is the Immunovia publ AB Stock Price Today?
The Immunovia publ AB stock price today is 0.40.
What Is the Stock Symbol for Immunovia publ AB?
The stock symbol for Immunovia publ AB is ""IMMNOV.""
What Stock Exchange Does Immunovia publ AB Trade On?
Immunovia publ AB is listed and trades on the Stockholm stock exchange.
Is Immunovia publ AB a Good Stock to Buy?
Determining whether Immunovia publ AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IMMNOV quote. (ISIN: SE0006091997)
What Is the Immunovia publ AB Stock Price Today?
The Immunovia publ AB stock price today is 0.40.
What Is the Stock Symbol for Immunovia publ AB?
The stock symbol for Immunovia publ AB is ""IMMNOV.""
What Stock Exchange Does Immunovia publ AB Trade On?
Immunovia publ AB is listed and trades on the Stockholm stock exchange.
Is Immunovia publ AB a Good Stock to Buy?
Determining whether Immunovia publ AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IMMNOV quote. (ISIN: SE0006091997)
Stockholm
Currency in SEK
0.40
-0.01(-2.48%)
Closed·
Fair Value
An estimate of a Immunovia publ AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.40
0.43
52 wk Range
0.24
1.05
IMMNOV Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
IMMNOV is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Immunovia publ AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.400.43
52 wk Range
0.241.05
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IMMNOV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Immunovia publ AB's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Immunovia publ AB Company Profile
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Immunovia publ AB Earnings Call Summary for Q2/2025
- Immunovia's stock dropped 20.33% after Q2 2025 earnings call, despite upcoming PancreasSure test launch on September 2, 2025
- Operating expenses reduced 17% YoY; cash burn rate at $6M/month, below projections; planned rights issue of 100M SEK with 80M SEK guaranteed
- Company targets 15-20 high-risk surveillance center adoptions by end of 2025; expects Medicare reimbursement by mid-2026
- CEO emphasizes mission progress; experts highlight test's potential impact on early pancreatic cancer detection
- Challenges include market saturation, financial strain, reimbursement uncertainties, and adoption by surveillance centers
Last Updated: 28/08/2025, 15:04
Read Full TranscriptCompare IMMNOV to Peers and Sector
Metrics to compare | IMMNOV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIMMNOVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.8x | −19.8x | −0.6x | |
PEG Ratio | −0.01 | −0.27 | 0.00 | |
Price/Book | 6.9x | 4.0x | 2.6x | |
Price / LTM Sales | 133.2x | 4.2x | 3.4x | |
Upside (Analyst Target) | 67.5% | 0.0% | 35.5% | |
Fair Value Upside | Unlock | 0.4% | 3.7% | Unlock |
Earnings
Latest Release
Aug 28, 2025
EPS / Forecast
-0.1089 / -0.09
Revenue / Forecast
100.00K / --
People Also Watch
FAQ
What Stock Exchange Does Immunovia publ AB Trade On?
Immunovia publ AB is listed and trades on the Stockholm Stock Exchange stock exchange.
What Is the Stock Symbol for Immunovia publ AB?
The stock symbol for Immunovia publ AB is "IMMNOV."
What Is the Immunovia publ AB Market Cap?
As of today, Immunovia publ AB market cap is 121.06M.
What Is Immunovia publ AB's Earnings Per Share (TTM)?
The Immunovia publ AB EPS (TTM) is -0.76.
When Is the Next Immunovia publ AB Earnings Date?
Immunovia publ AB will release its next earnings report on 18 Nov 2025.
From a Technical Analysis Perspective, Is IMMNOV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Immunovia publ AB Stock Split?
Immunovia publ AB has split 1 times.
How Many Employees Does Immunovia publ AB Have?
Immunovia publ AB has 8 employees.
What is the current trading status of Immunovia publ AB (IMMNOV)?
As of 05 Oct 2025, Immunovia publ AB (IMMNOV) is trading at a price of 0.40, with a previous close of 0.40. The stock has fluctuated within a day range of 0.40 to 0.43, while its 52-week range spans from 0.24 to 1.05.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.